MaaT Pharma SA (EPA:MAAT)
France · Delayed Price · Currency is EUR 4.140
+0.100 (2.48%)
At close: Nov 28, 2025
MaaT Pharma Market Cap
MaaT Pharma has a market cap or net worth of €66.68 million as of November 28, 2025. Its market cap has decreased by -41.77% in one year.
Market Cap
66.68M
Enterprise Value
66.04M
Revenue
3.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.14
Market Cap Chart
Since November 8, 2021, MaaT Pharma's market cap has decreased from 132.73M to 66.68M, a decrease of -49.77%. That is a compound annual growth rate of -15.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 66.68M | -39.72% |
| Dec 31, 2024 | 110.61M | 36.57% |
| Dec 29, 2023 | 80.99M | 2.32% |
| Dec 30, 2022 | 79.15M | -40.01% |
| Dec 31, 2021 | 131.95M | -0.59% |
| Nov 8, 2021 | 132.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 144.39B |
| Sanofi | 104.51B |
| Sartorius Stedim Biotech | 19.75B |
| bioMérieux | 12.90B |
| Eurofins Scientific SE | 10.50B |
| Ipsen | 10.22B |
| ABIVAX Société Anonyme | 8.45B |
| Virbac | 3.09B |